MyShare
Key factors
| sym | PRPO |
| exch | US |
| MCap | 9540.03K |
| Beta | 1.252 |
| EPS | -4.51 |
| Div date | 0000-00-00 |
Yesterday
| sym | PRPO |
| exch | US |
| close | 5.86 |
| 50 Day MA | 6.407 |
| 200 Day MA | 6.678 |
| 52 Week High | 14.8 |
| 52 Week Low | 4.751 |
| Target Price | 19.0 |
| Market Cap Mln | 9.54 |
Share statistics
| Shares Outstanding | 1430.29K |
| Shares Float | 1386.1K |
| Percent Institutions | 10.37 |
| PercentInsiders | 4.423 |
| SharesShort | 5273.0 |
| Short Ratio | 1.82 |
| Shares Short Prior Month | 5039.0 |
| Short Percent | 0.380 |
Income
| Revenue TTM | 15.19M |
| Revenue Per Share TTM | 11.70 |
| Quarterly Revenue Growth YOY | 81.09 |
| Gross Profit TTM | 2392.0K |
| EBITDA | -6312.0K |
| Diluted Eps TTM | -4.51 |
earning
| Operating Margin TTM | -0.19 |
| EPS Estimate Current Quarter | -0.93 |
| EPS Estimate Current Year | -6.25 |
| EPS Estimate Next Quarter | -0.7 |
| EPS Estimate Next Year | 0.39 |
| Earnings Share | -4.51 |
Dividend
| Dividend Date | 2019-04-29 |
| Last Split Date | 2023-09-22 |
| Last Split Factor | 1:20 |
business
| Enterprise Value Ebitda | -2.11 |
| Enterprise Value Revenue | 0.600 |
| Book Value /share | 10.16 |
| Price Book MRQ | 0.659 |
| Price Sales TTM | 0.626 |
| ProfitMargin | -0.38 |
| ReturnOnAssetsTTM | -0.24 |
| ReturnOnEquityTTM | -0.38 |
Sector
| Gic Group | Health Care Equipment & Services |
| Gic Industry | Health Care Providers & Services |
| Gic Sector | Health Care |
| Gic Sub Industry | Health Care Services |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
Codes
| ISIN | US74019L5030 |
| CIK | 1043961 |
| Code | PRPO |
| CUSIP | 89365K404 |
| CountryISO | US |
| Currency Code | USD |
| Currency Name | US Dollar |
| Exchange | NASDAQ |
| Currency Symbol | $ |
fund
| Type | Common Stock |
| UpdatedAt | 2024-04-19 |
| Home Category | Domestic |
info
| Fiscal Year End | December |
| ForwardPE | 15.43 |
| Full Time Employees | 51.0 |
| IPODate | 2000-07-18 |
| MostRecent Quarter | 2023-12-31 |
Contact
| Name | Precipio Inc |
| Address | 4 Science Park, New Haven, CT, United States, 06511 |
| Country Name | USA |
| Phone | 203 787 7888 |
| Web URL | https://www.precipiodx.com |
| Logo URL | /img/logos/US/PRPO.png |
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; and COVID-19 antibody tests. It sells ICE- technology kits to bio-pharma customers. The company is based in New Haven, Connecticut.